WellCell Holdings Co., Limited reported a significant board overhaul effective 26 June 2026:
• Leadership Departures – Non-Executive Director Lin Qihao resigned to focus on other business commitments. – Independent Non-Executive Director (INED) Wong Che Man Eddy stepped down, relinquishing his roles as chairman of the Audit, Remuneration and Nomination Committees, and membership in the Investment Committee. – Both departing directors confirmed they have no outstanding claims against the company and no disagreements with the Board.
• New Independent Non-Executive Director – The Board appointed the Hon. Wu Hung Yuk Anna, JP, GBS, SBS, as INED. Wu, 75, is a seasoned legal professional with extensive public-service credentials, including prior roles on Hong Kong’s Legislative and Executive Councils and chairmanships of several regulatory bodies. – Terms: initial two-year appointment, subject to rotation and re-election; annual director’s remuneration set at HK$0.12 million, aligned with market benchmarks. Wu meets all Hong Kong Listing Rules independence criteria.
• Committee Re-alignments – Wu becomes chairlady of the Remuneration Committee and joins both the Audit and Nomination Committees. – Chairman and Executive Director Qian Fenglei assumes chair of the Nomination Committee and joins the Investment Committee. – INED Chan Wai Dune is appointed chairman of the Audit Committee.
• Current Board Composition – Executive Directors: Qian Fenglei (Chairman), Jia Zhengyi, Zhang Xiaolong. – INEDs: Dan Xi, Chan Wai Dune, Wu Hung Yuk Anna.
The Board expressed appreciation to the departing directors for their contributions and welcomed Wu’s appointment, emphasizing continuity in governance amid the leadership transition.
Comments